9 Meters Biopharma to Present at the Oppenheimer 33rd Annual Healthcare Conference

RALEIGH, NC / ACCESSWIRE / March 7, 2023 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today announced

Related Keywords

Dennis Riedl ,Al Medwar ,John Temperato ,Linkedin ,Meters Biopharma Inc View ,Facebook ,Meters Biopharma Inc ,Nasdaq ,Investor Relations Corporate Communications ,Chief Executive Officer ,Annual Healthcare ,Annual Report ,Quarterly Reports ,Investor Relations ,Corporate Communications ,Inc View ,Meters ,Iopharma ,Present ,Oppenheimer ,3rd ,Nnual ,Healthcare ,Conference ,